Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | |
| Cash Flows From Operating Activities | |
| Net Income | -31,719 |
| Depreciation Amortization | 636 |
| Accounts payable and accrued liabilities | 525 |
| Other Working Capital | 3,256 |
| Other Operating Activity | 1,433 |
| Operating Cash Flow | $-25,869 |
| Cash Flows From Investing Activities | |
| Change In Deposits | 18,000 |
| PPE Investments | -4,997 |
| Purchase Of Investment | -375,000 |
| Investing Cash Flow | $-361,997 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 52 |
| Other Financing Activity | 5,665 |
| Financing Cash Flow | $5,717 |
| Beginning Cash Position | 422,383 |
| End Cash Position | 40,234 |
| Net Cash Flow | $-382,149 |
| Free Cash Flow | |
| Operating Cash Flow | -25,869 |
| Capital Expenditure | -5,017 |
| Free Cash Flow | -30,886 |